If a new influenza strain suddenly appears, why does vaccine-induced B-cell affinity maturation lead to cross-protection, even though the vaccine was designed for a different strain?

💡 Explanation

Affinity maturation causes higher-affinity antibodies to be produced through somatic hypermutation and clonal selection, thus leading to increased cross-reactivity against related influenza strains, because the antibodies evolve to bind more effectively to conserved epitopes. Therefore, cross-protection arises from this improved binding, rather than original antigenic sin or a suppressed T-cell response.

• Which risk increases as a patient's regulatory T cell count declines following prolonged exposure to a novel viral antigen?
• Which failure mode becomes likely when an antibiotic drug concentration gradient exists within a bacterial biofilm due to outer membrane porin mutation?
• If the radius of a blood vessel decreases by half due to vasoconstriction, which consequence follows regarding blood flow, assuming constant pressure gradient and blood viscosity?
• Which process primarily causes increased blood pressure after administration of vasoconstrictors?
• A researcher investigates neurodegenerative disease protein aggregates in brain tissue. Why does ubiquitin-proteasome system impairment increase the risk of pathological aggregate accumulation?
• Why does rubbing the skin around an injury reduce pain, according to the gate control theory of pain?